StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)

Close on Nov 17, 2026Market cap $1.24BP/E –Yield –

Avalyn Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Avalyn Pharma's enterprise value was $1.06B on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.06B–

More Avalyn Pharma figures

See a number that looks wrong?